Byrn Recognized for Work in Solid State Chemistry of Drugs
AAPS presents Dale E. Wurster award to Stephen Byrn for his work in the field of solid state chemistry.
Stephen R. Byrn of Purdue University was named the recipient of the 2016 Dale E. Wurster Award for his work in the field of solid state chemistry of drugs from the American Association of Pharmaceutical Scientists (AAPS). The award was announced on Nov. 13, 2016, at the AAPS annual meeting in Denver, CO.
Bryn is credited with setting in motion the development of solid state chemistry of drugs with books and papers on the subject, the first of which were published in the mid-1970s. He has taught more than 100 short courses and has educated more than 50 doctorate students. He is cofounder of Purdue’s regulatory graduate programs and the Purdue-Kilimanjaro Sustainable Medicines in Africa Program. He has chaired several FDA and USP committees, is involved in The National Institute for Pharmaceutical Technology and Education, and is cofounder of SSCI, Inc.
Supported by the Dale E. Wurster Endowment, this award is given to individuals who have made significant contributions to the pharmaceutical sciences in the specific field of pharmaceutics.
Source: American Association of Pharmaceutical Scientists
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
